Cooperative Agreement U01DP006826
Award Date
9/30/24
Completion Date
9/29/29
Dollars Obligated
$3M
Funding Federal Agency
National Center for Chronic Disease Prevention and Health Promotion
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.135
Assistance Type
Cooperative Agreement
Place of Performance
Michigan, USA
Similar Awards
This federal Cooperative Agreement award, funded by the Centers for Disease Control and Prevention (CDC) under the Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135), provides $2,787,076.00 to The Regents of the University of California, San Francisco (UCSF) to develop and test novel telehealth technologies for the detection and management of glaucoma and other vision-threatening eye diseases in high-risk populations. The award, effective...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Centers for Research and Demonstration for Health Promotion and Disease Prevention (CFDA 93.135) program provides $1,000,000.00 to The Trustees of Columbia University in the City of New York to serve as a Coordinating Center for Sight Studies. The center will evaluate the effectiveness of telehealth-based programs to detect glaucoma among high-risk populations in community health settings. The...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,590,000 Cooperative Agreement under the Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135) to the Massachusetts Eye and Ear Infirmary. The 5-year award, effective September 30, 2024, will support the "Glaucoma and Retinopathy Screening Study" to develop, test, and evaluate innovative screening technologies and interventions for glaucoma and diabetic...
The University of Alabama at Birmingham (UAB) was awarded a $3,000,000 Cooperative Agreement under the Centers for Research and Demonstration for Health Promotion and Disease Prevention (CFDA 93.135) program administered by the National Center for Chronic Disease Prevention and Health Promotion. The purpose of this 5-year award, with a start date of September 30, 2024, is to implement an AI-based glaucoma screening program within Federally Qualified Health Centers. As a sub-award under this...
This federal Cooperative Agreement award of $2,000,000.00, provided by the Centers for Disease Control and Prevention (CDC) under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) program, is focused on transforming the built environment to create safe and equitable spaces for physical activity in Michigan. The award will fund research, interventions, and outreach initiatives aimed at addressing chronic disease prevention and management through environmental...
The National Eye Institute (NEI) has awarded a $1,448,874 Cooperative Agreement to The Regents of the University of California, San Francisco (UCSF) under the NEI Vision Research program (CFDA 93.867) to conduct the Village-Integrated Eye Worker Trial II (VIEW II) Extension. The goal of this 5-year study is to evaluate the effectiveness of a community-based eye disease screening intervention in Nepal that uses optical coherence tomography (OCT), intraocular pressure (IOP) assessment, and...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 Vision Research) totaling $718,397 to Northwestern University to conduct the "Health Equity and Access to Leverage Technology for Improved Diabetic Retinopathy Outcomes (HEAL-DR)" study. The project aims to address disparities in diabetic retinopathy, a leading cause of blindness, by using data from the Sight Outcomes Research Collaborative (SOURCE) to develop models that can better identify minority populations at...
This Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867) is supporting the development of equitable deep learning models for automated glaucoma screening. The $754,779 award, with a performance period from Sep 30, 2024 to Jul 31, 2029, aims to assess the performance equity of existing deep learning models, develop identity-conditioned generative models to improve data equality, and create fair identity normalization techniques to equalize...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), will fund a study to evaluate the impact of patient, neighborhood, and community characteristics on diabetic retinopathy screening and monitoring. The central hypothesis is that neighborhood and community factors, as measured by the Area Deprivation Index (ADI), will be as or more important than individual patient characteristics in explaining non-adherence to...
This $185,000 Project Grant award from the National Eye Institute (NEI) under CFDA 93.867 (Vision Research) supports research to discover novel disease-modifying therapies for the prevention and treatment of glaucoma. The primary awardee, the University of North Texas Health Science Center at Fort Worth, will employ computational pharmacology approaches to identify small molecule inhibitors that can interfere with the GREM1-BMP protein-protein interaction, a key pathogenic mechanism contributing...